# Pregabalin for the Prevention of Chemotherapy Induced Nausea and Vomiting

> **NCT04181346** · PHASE2 · UNKNOWN · sponsor: **Faculdade de Medicina do ABC** · enrollment: 82 (estimated)

## Conditions studied

- Nausea

## Interventions

- **DRUG:** Pregabalin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04181346
- **Lead sponsor:** Faculdade de Medicina do ABC
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-01
- **Primary completion:** 2020-02-28
- **Final completion:** 2020-02-28
- **Target enrollment:** 82 (ESTIMATED)
- **Last updated:** 2019-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04181346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04181346, "Pregabalin for the Prevention of Chemotherapy Induced Nausea and Vomiting". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04181346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*